Correlation Between Onyx Acquisition and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Onyx Acquisition and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onyx Acquisition and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Onyx Acquisition Co and Abcellera Biologics, you can compare the effects of market volatilities on Onyx Acquisition and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onyx Acquisition with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onyx Acquisition and Abcellera Biologics.

Diversification Opportunities for Onyx Acquisition and Abcellera Biologics

-0.12

Correlation Coefficient

Onyx Acquisition  Abcellera Biologics

Good diversification

The 3 months correlation between Onyx and Abcellera is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Onyx Acquisition Co and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Onyx Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onyx Acquisition Co are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Onyx Acquisition i.e., Onyx Acquisition and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Onyx Acquisition and Abcellera Biologics

Assuming the 90 days horizon Onyx Acquisition is expected to generate 5.12 times less return on investment than Abcellera Biologics. But when comparing it to its historical volatility, Onyx Acquisition Co is 5.5 times less risky than Abcellera Biologics. It trades about 0.04 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  275.00  in Abcellera Biologics on September 18, 2024 and sell it today you would earn a total of  11.00  from holding Abcellera Biologics or generate 4.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	58.73%
Values	Daily Returns

Onyx Acquisition Co  vs.  Abcellera Biologics

Onyx Acquisition

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Onyx Acquisition Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Onyx Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Abcellera Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Onyx Acquisition and Abcellera Biologics

The main advantage of trading using opposite Onyx Acquisition and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onyx Acquisition position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Onyx Acquisition Co and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.